17,010
Views
54
CrossRef citations to date
0
Altmetric
Review

Advances in phototherapy for psoriasis and atopic dermatitis

ORCID Icon, &
Pages 1205-1214 | Received 12 Jul 2019, Accepted 23 Sep 2019, Published online: 01 Oct 2019

References

  • Matos TR, Ling TC, Sheth V. Ultraviolet B radiation therapy for psoriasis: pursuing the optimal regime. Clin Dermatol. 2016;34:587–593.
  • Kaushik SB, Lebwohl MG. Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol. 2019;80:27–40.
  • Kaushik SB, Lebwohl MG. Psoriasis: which therapy for which patient: focus on special populations and chronic infections. J Am Acad Dermatol. 2019;80:43–53.
  • Sabat R, Wolk K, Loyal L, et al. T cell pathology in skin inflammation. Semin Immunopathol. 2019;41:359–377.
  • Derheimer FA, Hicks JK, Paulsen MT, et al. Psoralen-induced DNA interstrand cross-links block transcription and induce p53 in an ataxia-telangiectasia and rad3-related-dependent manner. Mol Pharmacol. 2009;75:599–607.
  • Bonis B, Kemeny L, Dobozy A, et al. 308 nm UVB excimer laser for psoriasis. Lancet. 1997;350:1522.
  • Kemeny L, Csoma Z, Bagdi E, et al. Targeted phototherapy of plaque-type psoriasis using ultraviolet B-light-emitting diodes. Br J Dermatol. 2010;163:167–173.
  • Nishida E, Furuhashi T, Kato H, et al. Successful treatment of psoriasis vulgaris with targeted narrow-band ultraviolet B therapy using a new flat-type fluorescent lamp. Photodermatol Photoimmunol Photomed. 2011;27:248–250.
  • Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis. 2007;10:149–166.
  • Archid R, Patzelt A, Lange-Asschenfeldt B, et al. Confocal laser-scanning microscopy of capillaries in normal and psoriatic skin. J Biomed Opt. 2012;17:101511.
  • Nasca MR, Lacarrubba F, Caltabiano R, et al. Image gallery: reproduction of the Auspitz sign by videodermatoscopy, confocal microscopy and horizontal histopathology. Br J Dermatol. 2019;180:e178.
  • Heng MC, Allen SG, Haberfelde G, et al. Electron microscopic and immunocytochemical studies of the sequence of events in psoriatic plaque formation following tape-stripping. Br J Dermatol. 1991;125:548–556.
  • Varricchi G, Granata F, Loffredo S, et al. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol. 2015;73:144–153.
  • Hacker SM, Rasmussen JE. The effect of flash lamp-pulsed dye laser on psoriasis. Arch Dermatol. 1992;128:853–855.
  • Racz E, de Leeuw J, Baerveldt EM, et al. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis. Lasers Surg Med. 2010;42:201–210.
  • Syed S, Weibel L, Kennedy H, et al. A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis. Clin Exp Dermatol. 2008;33:243–248.
  • Kartal SP, Canpolat F, Gonul M, et al. Long-pulsed nd: YAG laser treatment for nail psoriasis. Dermatol Surg. 2018;44:227–233.
  • Tawfik AA. Novel treatment of nail psoriasis using the intense pulsed light: a one-year follow-up study. Dermatol Surg. 2014;40:763–768.
  • Oh SH, Bae BK, Kim TG, et al. Effective treatment of facial redness caused by atopic dermatitis using intense pulsed light systems. Dermatol Surg. 2010;36:475–482.
  • Schneider LA, Hinrichs R, Scharffetter-Kochanek K. Phototherapy and photochemotherapy. Clin Dermatol. 2008;26:464–476.
  • Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol. 1999;140:995–1009.
  • Baden HP, Parrington JM, Delhanty JD, et al. DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light. Biochim Biophys Acta. 1972;262:247–255.
  • Walter JF, Kelsey WH, Voorhees JJ, et al. Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol. 1973;107:861–865.
  • Wenk J, Brenneisen P, Meewes C, et al. UV-induced oxidative stress and photoaging. Curr Probl Dermatol. 2001;29:83–94.
  • Kostovic K, Pasic A. Phototherapy of psoriasis: review and update. Acta Dermatovenerol Croat. 2004;12:42–50.
  • Gonzalez E. PUVA for psoriasis. Dermatol Clin. 1995;13:851–866.
  • Staberg B. Psoriasis. Transcapillary and interstitial transport of plasma proteins, cutaneous blood, flow, and effect of phototherapy. Dan Med Bull. 1985;32:295–308.
  • Schade N, Esser C, Krutmann J. Ultraviolet B radiation-induced immunosuppression: molecular mechanisms and cellular alterations. Photochem Photobiol Sci. 2005;4:699–708.
  • Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189:711–718.
  • Novak Z, Bonis B, Baltas E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B. 2002;67:32–38.
  • Novak Z, Berces A, Ronto G, et al. Efficacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem Photobiol. 2004;79:434–439.
  • Weatherhead SC, Farr PM, Jamieson D, et al. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol. 2011;131:1916–1926.
  • Kagen MH, McCormick TS, Cooper KD. Regulatory T cells in psoriasis. Ernst Schering Res Found.Workshop. 2006; 193–209.
  • Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation. 2004;77:S29–S31.
  • Kripke ML, Morison WL, Parrish JA. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol. 1983;81:87–92.
  • Sethi G, Sodhi A. Role of p38 mitogen-activated protein kinase and caspases in UV-B-induced apoptosis of murine peritoneal macrophages. Photochem Photobiol. 2004;79:48–54.
  • Weitzen ML, Bonavida B. Mechanism of inhibition of human natural killer activity by ultraviolet radiation. J Immunol. 1984;133:3128–3132.
  • Kasahara S, Aizawa K, Okamiya M, et al. UVB irradiation suppresses cytokine production and innate cellular immune functions in mice. Cytokine. 2001;14:104–111.
  • Krueger JG, Wolfe JT, Nabeya RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med. 1995;182:2057–2068.
  • Teunissen MB, Piskin G, Di Nuzzo S, et al. Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, which support the development of Th2 responses. J Immunol. 2002;168:3732–3739.
  • Singh TP, Schon MP, Wallbrecht K, et al. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol. 2010;184:7257–7267.
  • Singh TP, Schon MP, Wallbrecht K, et al. 8-Methoxypsoralen plus UVA treatment increases the proportion of CLA+ CD25+ CD4+ T cells in lymph nodes of K5.hTGFbeta1 transgenic mice. Exp Dermatol. 2012;21:228–230.
  • Schweintzger N, Gruber-Wackernagel A, Reginato E, et al. Levels and function of regulatory T cells in patients with polymorphic light eruption: relation to photohardening. Br J Dermatol. 2015;173:519–526.
  • Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–527.
  • Hockberger PE, Skimina TA, Centonze VE, et al. Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells. Proc Natl Acad Sci USA. 1999;96:6255–6260.
  • Ohara M, Fujikura T, Fujiwara H. Augmentation of the inhibitory effect of blue light on the growth of B16 melanoma cells by riboflavin. Int J Oncol. 2003;22:1291–1295.
  • Lewis JB, Wataha JC, Messer RL, et al. Blue light differentially alters cellular redox properties. J Biomed Mater Res B Appl Biomater. 2005;72:223–229.
  • Karu TI, Afanas’eva NI. Cytochrome c oxidase as the primary photoacceptor upon laser exposure of cultured cells to visible and near IR-range light. Dokl Akad Nauk. 1995;342:693–695.
  • Stadler I, Evans R, Kolb B, et al. In vitro effects of low-level laser irradiation at 660 nm on peripheral blood lymphocytes. Lasers Surg Med. 2000;27:255–261.
  • Liebmann J, Born M, Kolb-Bachofen V. Blue-light irradiation regulates proliferation and differentiation in human skin cells. J Invest Dermatol. 2010;130:259–269.
  • Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359–362.
  • Coven TR, Burack LH, Gilleaudeau R, et al. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997;133:1514–1522.
  • Kirke SM, Lowder S, Lloyd JJ, et al. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis. J Invest Dermatol. 2007;127:1641–1646.
  • Bruls WA, Slaper H, van der Leun JC, et al. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochem Photobiol. 1984;40:485–494.
  • Welzel J, Bruhns M, Wolff HH. Optical coherence tomography in contact dermatitis and psoriasis. Arch Dermatol Res. 2003;295:50–55.
  • Chapman DM, Ross JB. Objective measurement of three epidermal parameters in psoriasis vulgaris and in dermatopathology in general. Br J Dermatol. 1988;119:333–343.
  • Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77:13–19.
  • Gerber W, Arheilger B, Ha TA, et al. Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach. Br J Dermatol. 2003;149:1250–1258.
  • Nghiem DX, Kazimi N, Mitchell DL, et al. Mechanisms underlying the suppression of established immune responses by ultraviolet radiation. J Invest Dermatol. 2002;119:600–608.
  • Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23(Suppl 2):1–70.
  • Moseley H, Allan D, Amatiello H, et al. Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015. Br J Dermatol. 2015;173:333–350.
  • Zhang P, Wu MX. A clinical review of phototherapy for psoriasis. Lasers Med Sci. 2018;33:173–180.
  • Hofbauer G. Phototherapy and carcinogenesis. Hautarzt. 2013;64:349–353.
  • Asawanonda P, Anderson RR, Chang Y, et al. 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol. 2000;136:619–624.
  • Kemeny L, Bonis B, Dobozy A, et al. 308-nm excimer laser therapy for psoriasis. Arch Dermatol. 2001;137:95–96.
  • Farkas A, Kemeny L. Applications of the 308-nm excimers lasers in dermatology. Laser Phys. 2006;16:876–883.
  • Kollner K, Wimmershoff MB, Hintz C, et al. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol. 2005;152:750–754.
  • Hum M, Kalia S, Gniadecki R. Prescribing home narrowband UVB phototherapy: a review of current approaches. J Cutan Med Surg. 2019;23:91–96.
  • Franken SM, Vierstra CL, Rustemeyer T. Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects. Psoriasis (Auckl). 2016;6:55–64.
  • Cline A, Unrue EL, Collins A, et al. Adherence to a novel home phototherapy system with integrated features. Dermatol Online J. 2019;25(3).
  • Anderson KL, Huang KE, Huang WW, et al. Dermatology residents are prescribing tanning bed treatment. Dermatol Online J. 2016;22(7).
  • Katugampola GA, Rees AM, Lanigan SW. Laser treatment of psoriasis. Br J Dermatol. 1995;133:909–913.
  • Ros AM, Garden JM, Bakus AD, et al. Psoriasis response to the pulsed dye laser. Lasers Surg Med. 1996;19:331–335.
  • Hern S, Allen MH, Sousa AR, et al. Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol. 2001;145:45–53.
  • Zelickson BD, Mehregan DA, Wendelschfer-Crabb G, et al. Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. J Am Acad Dermatol. 1996;35:64–68.
  • Erceg A, Bovenschen HJ, van de Kerkhof PC, et al. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study. Br J Dermatol. 2006;155:110–114.
  • de Leeuw J, Tank B, Bjerring PJ, et al. Concomitant treatment of psoriasis of the hands and feet with pulsed dye laser and topical calcipotriol, salicylic acid, or both: a prospective open study in 41 patients. J Am Acad Dermatol. 2006;54:266–271.
  • Youssef NY, Saleh HM, Abdallah MA. Pulsed dye laser in the treatment of psoriatic nails: a controlled study. J Eur Acad Dermatol Venereol. 2017;31:e49–e50.
  • Maari C, Viau G, Bissonnette R. Repeated exposure to blue light does not improve psoriasis. J Am Acad Dermatol. 2003;49:55–58.
  • Kleinpenning MM, Otero ME, van Erp PE, et al. Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study. J Eur Acad Dermatol Venereol. 2012;26:219–225.
  • Pfaff S, Liebmann J, Born M, et al. Prospective randomized long-term study on the efficacy and safety of UV-free blue light for treating mild psoriasis vulgaris. Dermatology. 2015;231:24–34.
  • Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327–349.
  • Boguniewicz M, Alexis AF, Beck LA, et al. Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies. J Allergy Clin Immunol Pract. 2017;5:1519–1531.
  • Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32:657–682.
  • Patrizi A, Raone B, Ravaioli GM. Management of atopic dermatitis: safety and efficacy of phototherapy. Clin Cosmet Investig Dermatol. 2015;8:511–520.
  • Reynolds NJ, Franklin V, Gray JC, et al. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet. 2001;357:2012–2016.
  • Legat FJ, Hofer A, Brabek E, et al. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol. 2003;139:223–224.
  • Baltas E, Csoma Z, Bodai L, et al. Treatment of atopic dermatitis with the xenon chloride excimer laser. J Eur Acad Dermatol Venereol. 2006;20:657–660.
  • Morita H, Kohno J, Hori M, et al. Clinical application of low reactive level laser therapy (LLLT) for atopic dermatitis. Keio J Med. 1993;42:174–176.
  • Becker D, Langer E, Seemann M, et al. Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis. PLoS ONE. 2011;6:e20566.
  • Keemss K, Pfaff SC, Born M, et al. Prospective, randomized study on the efficacy and safety of local UV-free blue light treatment of eczema. Dermatology. 2016;232:496–502.
  • Kromer C, Nuhnen VP, Pfutzner W, et al. Treatment of atopic dermatitis using a full-body blue light device (AD-Blue): protocol of a randomized controlled trial. JMIR Res Protoc. 2019;8:e11911.
  • Housman TS, Rohrback JM, Fleischer AB, et al. Phototherapy utilization for psoriasis is declining in the United States. J Am Acad Dermatol. 2002;46:557–559.
  • Tan SY, Buzney E, Mostaghimi A. Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015. J Am Acad Dermatol. 2018;79:672–679.